| ASSET | YEAR | % RETURN |
|---|---|---|
Achieve Life Sciences (ACHV) | 2007 | -92.98% |
Amarin (AMRN) | 2007 | -88.5% |
Savara (SVRA) | 2007 | -84.75% |
Beazer Homes USA (BZH) | 2007 | -83.9% |
Red Cat (RCAT) | 2007 | -80% |
Hovnanian Enterprises (HOV) | 2007 | -78.75% |
Atlanticus (ATLC) | 2007 | -74.95% |
MBIA (MBI) | 2007 | -73.95% |
Vanda Pharmaceuticals (VNDA) | 2007 | -72.48% |
Oxley Bridge Acquisition Limited Class A Ordinary Shares (OBA) | 2007 | -68.82% |
Onity (ONIT) | 2007 | -65.16% |
STAAR Surgical (STAA) | 2007 | -62.61% |
Rocky Brands (RCKY) | 2007 | -62.18% |
Hanmi Financial (HAFC) | 2007 | -61.44% |
Mitek Systems (MITK) | 2007 | -61.39% |
Citi Trends (CTRN) | 2007 | -61.04% |
Independent Bank (IBCP) | 2007 | -60.5% |
BlueLinx (BXC) | 2007 | -59.77% |
Perspective Therapeutics (CATX) | 2007 | -59.39% |
Eyepoint Pharmaceuticals (EYPT) | 2007 | -59.28% |
Wendy’s (WEN) | 2007 | -59% |
LightPath Technologies (LPTH) | 2007 | -58.82% |
MGP Ingredients (MGPI) | 2007 | -58.22% |
Allot Communications (ALLT) | 2007 | -57.64% |
Sarepta Therapeutics (SRPT) | 2007 | -56.07% |
Small-cap stocks are treated as having a market cap between $300M and $2B.